Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Homad LJ"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.
Autorzy:
Hurlburt NK; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Homad LJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Sinha I; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Jennewein MF; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
MacCamy AJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Wan YH; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Boonyaratanakornkit J; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Sholukh AM; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Jackson AM; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
Zhou P; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.
Andrabi R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.
Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
Stamatatos L; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. .; Department of Global Health, University of Washington, Seattle, WA, USA. .
Pancera M; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. .; Vaccine Research Center, NAID, NIH, Bethesda, MD, USA. .
McGuire AT; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. .; Department of Global Health, University of Washington, Seattle, WA, USA. .; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2022 Apr 11; Vol. 5 (1), pp. 342. Date of Electronic Publication: 2022 Apr 11.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*
SARS-CoV-2*
Animals ; Antibodies, Monoclonal ; Antibodies, Neutralizing ; Antibodies, Viral ; Epitopes ; Spike Glycoprotein, Coronavirus/chemistry
SCR Organism:
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł:
Designed proteins assemble antibodies into modular nanocages.
Autorzy:
Divine R; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Dang HV; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Ueda G; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Fallas JA; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Vulovic I; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Sheffler W; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Saini S; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Zhao YT; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.; Oral Health Sciences, School of Dentistry, University of Washington, Seattle, WA 98195, USA.
Raj IX; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Morawski PA; Benaroya Research Institute, Seattle, WA 98101, USA.
Jennewein MF; Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98019, USA.
Homad LJ; Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98019, USA.
Wan YH; Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98019, USA.
Tooley MR; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Seeger F; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Etemadi A; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Medical Biotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Fahning ML; Benaroya Research Institute, Seattle, WA 98101, USA.
Lazarovits J; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Roederer A; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Walls AC; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Stewart L; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Mazloomi M; Medical Biotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
King NP; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.
Campbell DJ; Benaroya Research Institute, Seattle, WA 98101, USA.
McGuire AT; Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98019, USA.; Department of Global Health, University of Washington, Seattle, WA 98195, USA.
Stamatatos L; Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98019, USA.; Department of Global Health, University of Washington, Seattle, WA 98195, USA.
Ruohola-Baker H; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.
Mathieu J; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA 98109, USA.; Department of Comparative Medicine, University of Washington, Seattle, WA 98195, USA.
Veesler D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
Baker D; Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. .; Institute for Protein Design, University of Washington, Seattle, WA 98195, USA.; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2021 Apr 02; Vol. 372 (6537).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Nanostructures*
Protein Engineering*
Signal Transduction*
Antibodies/*chemistry
Antibodies/*immunology
Angiopoietins/chemistry ; Angiopoietins/immunology ; Angiopoietins/metabolism ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/chemistry ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/chemistry ; Antibodies, Viral/immunology ; B-Lymphocytes/immunology ; CD40 Antigens/chemistry ; CD40 Antigens/immunology ; CD40 Antigens/metabolism ; Cell Line, Tumor ; Cell Proliferation ; Computer Simulation ; Genes, Synthetic ; Humans ; Immunoglobulin Fc Fragments/chemistry ; Lymphocyte Activation ; Models, Molecular ; Protein Binding ; Receptor, TIE-2/metabolism ; Receptors, TNF-Related Apoptosis-Inducing Ligand/immunology ; Receptors, TNF-Related Apoptosis-Inducing Ligand/metabolism ; SARS-CoV-2/immunology ; T-Lymphocytes/immunology ; T-Lymphocytes/physiology
Czasopismo naukowe
Tytuł:
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
Autorzy:
Stamatatos L; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. .; Department of Global Health, University of Washington, Seattle, WA, USA.
Czartoski J; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Wan YH; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Homad LJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Rubin V; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Glantz H; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Neradilek M; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Seydoux E; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Jennewein MF; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
MacCamy AJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Feng J; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Mize G; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
De Rosa SC; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Finzi A; Centre de Recherche du CHUM, Montréal, QC, Canada.; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC, Canada.; Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
Lemos MP; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Cohen KW; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
Moodie Z; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA.
McElrath MJ; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. .; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.
McGuire AT; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Disease Division, Seattle, WA, USA. .; Department of Global Health, University of Washington, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2021 Mar 25. Date of Electronic Publication: 2021 Mar 25.
Typ publikacji:
Editorial
Opinia redakcyjna
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies